期刊文献+

Wnt信号通路靶基因GS mRNA及蛋白在胃癌中的表达 被引量:4

Expression of the new target GS mRNA and protein of Wnt signaling pathway in gastric cancerous tissue
暂未订购
导出
摘要 目的:探讨Wnt信号通路的靶基因GS mRNA及蛋白在胃癌中的表达及其临床意义.方法:荧光实时定量PCR(FQ-PCR)检测52例胃癌组织及癌旁正常组织GS mRNA表达;免疫组织化学技术(SP法)检测97例胃癌组织、30例癌旁正常组织及10例肠化生组织中GS蛋白表达水平差异.结果:癌组织和癌旁正常组织GS mRNA表达有显著差异(25.508±5.090vs13.001±2.040,P<0.05).癌组织GS蛋白表达与组织学类型、Lauren分型及淋巴结转移密切相关(χ=26.994,54.929,5.173,均P<0.05),与肿瘤大小、TNM分期、远处转移及患者的性别和年龄等无明显相关.结论:GSmRNA和蛋白高表达同胃癌生物学行为密切相关,可能与胃癌的发生、发展及预后有关. AIM: To investigate the new target of Wnt signaling pathway GS mRNA and protein expression in cancerous tissue from patients with gastric carcinoma and to evaluate its clinic significance. METHODS: Fluorescent quantitative PCR (FQPCR) was used to detect the GS mRNA expression in cancerous tissue and paracancerous normal mucosa from 52 patients with gastric carcinoma. Immunohistochemistry (SP method) was used to detect GS expressions in paraffinembedded gastric carcinoma tissues of 97 cases, paracancerous normal mucosa of 30 cases and 10 intestinal metaplasia tissues. RESULTS: The expression of GS mRNA was significantly higher in cancerous tissue from patients with gastric carcinoma than in normal tissue (25.508 ± 5.090 vs 13.001 ± 2.040, P 〈 0.05). GS protein expression was closely related to the pathologic parameters, such as histological type, Lauren classification and distant metastasis (X^2 = 26.994, 54.929, 5.173, all P 〈 0.05). However, there was no significant correlation between GS expression and lymph node metastasis, tumor size, TNM staging, age and gender of patients. CONCLUSION: GS mRNA and protein expression is significantly correlated with the biological behavior of gastric carcinoma. The high expression of GS may be related with the occurrence and progress of gastric cancer.
出处 《世界华人消化杂志》 CAS 北大核心 2009年第17期1777-1781,共5页 World Chinese Journal of Digestology
关键词 WNT信号通路 胃癌 谷氨酰胺合成酶 免疫组织化学 Wnt signaling pathway Gastric cancer Glutamine synthetase Immunohistochernistry
  • 相关文献

参考文献1

二级参考文献31

  • 1[1]Pishvaian MJ,Byers SW.Biomarkers of WNT signaling.Cancer Biomark 2007;3:263-274
  • 2[2]Neth P,Ries C,Karow M,Egea V,Ilmer M,Jochum M.The Wnt signal transduction pathway in stem cells and cancer cells:influence on cellular invasion.Stem Cell Rev 2007;3:18-29
  • 3[3]Herbst A,Kolligs FT.Wnt signaling as a therapeutic target for cancer.Methods Mol Biol 2007;361:63-91
  • 4[4]Akiyama T.Wnt/beta-catenin signaling.Cytokine Growth Factor Rev 2000;11:273-282
  • 5[5]Kikuchi A.Modulation of Wnt signaling by Axin and Axil.Cytokine Growth Factor Rev 1999;10:255-265
  • 6[6]Satoh S,Daigo Y,Furukawa Y,Kato T,Miwa N,Nishiwaki T,Kawasoe T,Ishiguro H,Fujita M,Tokino T,Sasaki Y,Imaoka S,Murata M,Shimano T,Yamaoka Y,Nakamura Y.AXIN1 mutations in hepatocellular carcinomas,and growth suppression in cancer cells by virus-mediated transfer of AXIN1.Nat Genet 2000;24:245-250
  • 7[7]Liu W,Dong X,Mai M,Seelan RS,Taniguchi K,Krishnadath KK,Hailing KC,Cunningham JM,Boardman LA,Qian C,Christensen E,Schmidt SS,Roche PC,Smith DI,Thibodeau SN.Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling.Nat Genet 2000;26:146-147
  • 8[8]Behrens J,Jerchow BA,Wurtele M,Grimm J,Asbrand C,Wirtz R,Kuhl M,Wedlich D,Birchmeier W.Functional interaction of an axin homolog,conductin,with beta-catenin,APC,and GSK3beta.Science 1998;280:596-599
  • 9[9]Hart MJ,de los Santos R,Albert IN,Rubinfeld B,Polakis P.Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor,beta-catenin and GSK3 beta.Curr Biol 1998;8:573-581
  • 10[10]Dahmen RP,Koch A,Denkhaus D,Tonn JC,Sorensen N,Berthold F,Behrens J,Birchmeier W,Wiestler OD,Pietsch T.Deletions of AXIN1,a component of the WNT/wingless pathway,in sporadic medulloblastomas.Cancer Res 2001;61:7039-7043

共引文献10

同被引文献6

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部